CALIWAY BIOPHARMACEUTICALS CO LTD earnings per share and revenue

6919 earnings per share for the last quarter are -1.36 TWD whereas the estimation was -1.25 TWD which accounts for -8.80% surprise. Company revenue for the same period amounts to 9.00 M TWD despite the estimated figure of 8.00 M TWD. Estimated earnings per share for the next quarter are -1.57 TWD, and revenue is expected to reach 4.00 M TWD. Also watch annual changes over time to get a bigger picture of 6919 earnings per share and revenue dynamics.